S. Schimpff

发表

Empiric antibiotic therapy for granulocytopenic cancer patients.

S. Schimpff, 1986, The American journal of medicine.

Microbiology of acute periodontal infection in myelosuppressed cancer patients.

D. Peterson, S. Schimpff, C. Overholser, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infection in the Severely Traumatized Patient

R. Hornick, S. Schimpff, Roger M. Miller, 1974, Annals of surgery.

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

G. D. Vermeulen, P. Wiernik, S. Schimpff, 1972, Annals of internal medicine.

Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.

J. Aisner, P. Wiernik, S. Schimpff, 1977, Annals of internal medicine.

Staphylococcus aureus bacteremia in patients with acute leukemia.

S. Sotman, S. Schimpff, V. M. Young, 1980, The American journal of medicine.

Effect of Two Cancer Chemotherapeutic Agents on the Antibacterial Activity of Three Antimicrobial Agents

L. Moyé, P. Wiernik, S. Schimpff, 1978, Antimicrobial Agents and Chemotherapy.

Comparison of basic infection prevention techniques, with standard room reverse isolation or with reverse isolation plus added air filtration

P. Wiernik, S. Schimpff, V. M. Young, 1978 .

Infection in Acute Leukemia Patients Receiving Oral Nonabsorbable Antibiotics

P. Wiernik, S. Schimpff, V. M. Young, 1978, Antimicrobial Agents and Chemotherapy.

Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.

G. Drusano, D. Johnson, H. Standiford, 1985, The American journal of medicine.

Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer.

W. P. Reed, J. Tenney, J. Costerton, 1986, Archives of internal medicine.

The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017

D. Graham, R. Baldassano, L. Sechi, 2017, Front. Public Health.

Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient.

S. Schimpff, P. Pizzo, 1983, Cancer treatment reports.

Infection among 210 patients with surgically staged Hodgkin's disease.

J. J. Coleman, D. Morris, P. Wiernik, 1983, The American journal of medicine.

Infections in 92 splenectomized patients with Hodgkin's disease. A clinical review.

M. O’connell, P. Wiernik, S. Schimpff, 1975, The American journal of medicine.

Infection in the Patient with Cancer

S. Schimpff, 1989 .

Leukemia and lymphoma patients linked by prior social contact. Evaluation using a case-control approach.

G. Comstock, P. Wiernik, S. Schimpff, 1976, Annals of internal medicine.

LEUKÆMIA AND LYMPHOMA PATIENTS INTERLINKED BY PRIOR SOCIAL CONTACT

P. Wiernik, S. Schimpff, D. Brager, 1975, The Lancet.

Two methods for improved venous access in acute leukemia patients.

W. P. Reed, P. Wiernik, S. Schimpff, 1981, JAMA.

Epidemiology and Prevention of Infection in the Compromised Host

S. Schimpff, J. Wade, 1988 .

Prevention of infection among patients with cancer.

T. Walsh, S. Schimpff, 1983, European journal of cancer & clinical oncology.

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.

P. Wiernik, S. Schimpff, J. Wade, 1981, The New England journal of medicine.

Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression.

S. Schimpff, 1980, Annals of internal medicine.

Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.

P. Wiernik, S. Schimpff, V. M. Young, 1974, The Journal of infectious diseases.

Pseudomonas septicemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer.

P. Wiernik, S. Schimpff, V. M. Young, 1973, European journal of cancer.

P. Wiernik, S. Schimpff, J. Wiswell, 1980, Annals of Internal Medicine.

GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

L. Young, R. Feld, D. Armstrong, 1997 .

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.

L. Young, R. Feld, D. Armstrong, 1990, The Journal of infectious diseases.

Relationship of colonization with Pseudomonas aeruginosa to development of Pseudomonas bacteremia in cancer patients.

S. Schimpff, V. M. Young, M. Moody, 1970, Antimicrobial agents and chemotherapy.

Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancer.

P. Wiernik, S. Schimpff, J. Wade, 1981, Archives of internal medicine.

Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

M. Tattersall, H. Gaya, J. Klastersky, 1978, The Journal of infectious diseases.

The value of routine bone marrow and cerebrospinal fluid cultures in patients with cancer--a negative report.

G. D. Vermeulen, P. Wiernik, S. Schimpff, 1973, American journal of clinical pathology.

Growth Factors and Empiric Therapy with Antibiotics: Should They Be Used Concurrently?

S. Schimpff, 1994, Annals of Internal Medicine.

Infections in the compromised host - an overview.

R. Douglas, J. Bennett, S. Schimpff, 1990 .

A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

J. Tenney, G. Drusano, R. Finley, 1986, The American journal of medicine.

Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

P. Wiernik, S. Schimpff, V. M. Young, 1973, Annals of internal medicine.

An analysis of Group D streptococci recovered from cancer patients

P. Wiernik, S. Schimpff, V. M. Young, 2005, Infection.

Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use.

A. Steere, J. Aisner, S. Schimpff, 1979, Annals of internal medicine.

Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.

M. Tattersall, T. Calandra, C. Viscoli, 1988, European journal of cancer & clinical oncology.

Please Don't Eat the Salads

J. Remington, S. Schimpff, 1981 .

Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemiologic, preventive and therapeutic research.

P. Wiernik, S. Schimpff, V. M. Young, 1981, The American journal of medicine.

Erratum: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever (J. Infec. Dis. 1990; 161:381-396)

L. Young, R. Feld, D. Armstrong, 1990 .

Varicella-Zoster infection in patients with cancer.

B. Rumack, S. Schimpff, J. Block, 1972, Annals of internal medicine.

Infections in cancer patients: some controversial issues

S. Schimpff, J. Wade, D. Scott, 1994, Supportive Care in Cancer.

Gram-negative bacteremia

S. Schimpff, 2004, Supportive Care in Cancer.

Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients

G. Drusano, J. Leslie, H. Standiford, 1985, Antimicrobial Agents and Chemotherapy.

Periodontal infection in patients with acute nonlymphocyte leukemia. Prevalence of acute exacerbations.

D. Peterson, S. Schimpff, C. Overholser, 1982, Archives of internal medicine.

Prevention of Infection in Cancer Patients

H. Senn, J. Klastersky, S. Schimpff, 1999 .

Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization.

J. Aisner, P. Wiernik, S. Schimpff, 1976, The American journal of medicine.

Molecular epidemiology of group JK Corynebacterium on a cancer ward: lack of evidence for patient-to-patient transmission.

R. Khabbaz, J. Tenney, J. Kaper, 1986, The Journal of infectious diseases.

Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients

H. Standiford, P. Wiernik, S. Schimpff, 1977, Antimicrobial Agents and Chemotherapy.

Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia

S. Schimpff, J. Wade, V. M. Young, 1981, Antimicrobial Agents and Chemotherapy.

A comparative trial of tobramycin vs gentamicin in combination with vancomycin and nystatin for alimentary tract suppression in leukemic patients.

J. Bender, P. Wiernik, S. Schimpff, 1979, European journal of cancer.

Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.

J. Bender, H. Standiford, P. Wiernik, 1979, The American journal of medicine.

Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients.

H. Standiford, S. Schimpff, M. Moody, 1986, The American journal of medicine.

Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.

T. Walsh, S. Schimpff, 1983, Schweizerische medizinische Wochenschrift. Supplementum.

Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia.

W. P. Reed, J. Costerton, J. Aisner, 1986, The American journal of the medical sciences.

A comparative evaluation of two fiberoptic bronchoscopy catheters: the plugged telescoping catheter versus the single sheathed nonplugged catheter.

P. Wiernik, S. Schimpff, K. P. Wang, 1982, The American review of respiratory disease.

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

P. Wiernik, S. Schimpff, J. Wade, 1982, Annals of internal medicine.

Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison.

G. Drusano, H. Standiford, S. Schimpff, 1984, Reviews of infectious diseases.

Febrile neutropenia, colony-stimulating factors and therapy: time for a new methodology?

G. Forrest, A. Cross, S. Schimpff, 2002, Supportive Care in Cancer.

Infections during intensive chemotherapy for non-Hodgkin's lymphoma.

P. Wiernik, S. Schimpff, J. Bishop, 1981, Annals of internal medicine.

Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease.

M. Mardiney, J. Ruckdeschel, S. Schimpff, 1977, The American journal of medicine.

The emergence of coryneform bacteria as a cause of nosocomial infections in compromised hosts.

S. Schimpff, V. M. Young, M. Moody, 1981, The American journal of medicine.

Gentamicin and ticarcillin serum levels.

H. Standiford, S. Schimpff, B. Tatem, 1979, JAMA.

Digitalis tolerance in young puppies.

S. Schimpff, N. Talner, K. Halloran, 1970, Pediatrics.

Aspergillus sinusitis in cancer patients

M. Moody, D. Peterson, S. Schimpff, 1986, Cancer.

Urinary polyamines in cancer patients.

C. Levy, S. Schimpff, D. Russell, 1971, Cancer research.

Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.

M. Tattersall, H. Gaya, J. Klastersky, 1975, European journal of cancer.

Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?

J. Tenney, S. Schimpff, J. Joshi, 1984, The American journal of medicine.

Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.

M. O’connell, C. Schiffer, J. Aisner, 1976, Cancer treatment reports.

Comprehensive textbook of oncology

A. Moossa, M. Robson, S. Schimpff, 1986 .

Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.

A. Levine, R. Young, S. Schimpff, 1974, Seminars in hematology.

Multiple-dose pharmacokinetics of imipenem-cilastatin

G. Drusano, J. Leslie, H. Standiford, 1984, Antimicrobial Agents and Chemotherapy.

Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.

S. Schimpff, C. D. de Jongh, M. Moody, 1982, JAMA.

The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers

G. Drusano, H. Standiford, A. Forrest, 1984, European Journal of Clinical Microbiology.

Persistent Isolation of an Unusual Pseudomonas Species From a Phenolic Disinfectant System

J. Tenney, S. Schimpff, M. Moody, 1984, Infection Control.

In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients

S. Schimpff, V. M. Young, M. Moody, 1980, Antimicrobial Agents and Chemotherapy.

Aspergillus sinusitis in neutropenic patients with cancer: a review.

D. Peterson, S. Schimpff, 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital.

J E Bennett, J. Bennett, J. Aisner, 1976, JAMA.

Therapy of infection in patients with granulocytopenia.

S. Schimpff, 1977, The Medical clinics of North America.

Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection.

J. Bennett, S. Schimpff, 1975, The Journal of allergy and clinical immunology.

Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.

J. Crowley, P. Wiernik, S. Schimpff, 1983, The Journal of infectious diseases.

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.

P. Wiernik, S. Schimpff, J. Block, 1975, Annals of internal medicine.

Diagnosis of infection in patients with cancer.

S. Schimpff, 1975, European journal of cancer.

Principles of Infection Management and Prevention

J. Aisner, S. Schimpff, 1983 .

Torulopsis glabrata pneumonitis in patients with cancer. Report of three cases.

E. Sickles, J. Aisner, P. Wiernik, 1974, JAMA.

The acylampicillins: mezlocillin, piperacillin, and azlocillin.

G. Drusano, W. Hewitt, S. Schimpff, 1984, Reviews of infectious diseases.

Correlation of predicted serum bactericidal activities and values measured in volunteers

G. Drusano, H. Standiford, S. Schimpff, 1986, European Journal of Clinical Microbiology.

Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicin.

G. Drusano, H. Standiford, S. Schimpff, 1985, The Journal of antimicrobial chemotherapy.

Comparison of the pharmacokinetics of ceftazidime and moxalactam and their microbiological correlates in volunteers

G. Drusano, J. Leslie, H. Standiford, 1984, Antimicrobial Agents and Chemotherapy.

Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin

G. Drusano, H. Standiford, S. Schimpff, 1984, Antimicrobial Agents and Chemotherapy.

Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.

G. Drusano, H. Standiford, S. Schimpff, 1982, Reviews of infectious diseases.

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

W Satterlee, S. Schimpff, V. M. Young, 1971, The New England journal of medicine.

Pirbenicillin: Comparison with Carbenicillin and BL-P1654, Alone and with Gentamicin, Against Pseudomonas aeruginosa

H. Standiford, R. Hornick, S. Schimpff, 1977, Antimicrobial Agents and Chemotherapy.

Hospital hotel services as risk factors for infection among immunocompromised patients.

S. Schimpff, K. Newman, 1987, Reviews of infectious diseases.

Empiric Carbenicillin, Gentamicin and Cephalothin Therapy for Presumed Infection in Patients with Granulocytopenia and Cancer.

P. Wiernik, S. Schimpff, V. M. Young, 1973 .

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

H. Gaya, J. Klastersky, S. Schimpff, 1986, Antimicrobial Agents and Chemotherapy.

Improved prognosis for granulocytopenic patients with gram-negative bacteremia.

C. Schiffer, P. Wiernik, S. Schimpff, 1980, The American journal of medicine.

Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients

P. Wiernik, S. Schimpff, J. Wade, 1980, Antimicrobial Agents and Chemotherapy.

Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.

R. Finley, H. Standiford, P. Wiernik, 1982, The American journal of medicine.

Transtracheal selective bronchial brushing for pulmonary infiltrates in patients with cancer.

E. Sickles, L. Kvols, J. Aisner, 1976, Chest.

Alloimmunization following prophylactic granulocyte transfusion.

C. Schiffer, J. Aisner, P. Wiernik, 1979, Blood.

Empiric antibiotic therapy.

J. Aisner, S. Schimpff, Schimpff Sc, 1978, Cancer treatment reports.

Overview of empiric antibiotic therapy for the febrile neutropenic patient.

S. Schimpff, 1985, Reviews of infectious diseases.

Relationship of Pseudomonas aeruginosa immunotypes to antibiotic susceptibility patterns.

S. Schimpff, V. M. Young, D. Kenton, 1970, Antimicrobial agents and chemotherapy.

Inappropriate Antidiuretic Hormone Following Adenine Arabinoside Administration

S. Schimpff, R. Timmons, E. Ramos, 1979, Antimicrobial Agents and Chemotherapy.

The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity.

H. Standiford, R. Hornick, S. Schimpff, 1974, Annals of internal medicine.

Comparative Activity of Tobramycin, Amikacin, and Gentamicin Alone and with Carbenicillin Against Pseudomonas aeruginosa

H. Standiford, R. Hornick, S. Schimpff, 1974, Antimicrobial Agents and Chemotherapy.

Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients

R. Finley, P. Wiernik, S. Schimpff, 1982, Antimicrobial Agents and Chemotherapy.

Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trial.

P. Wiernik, S. Schimpff, W. Greene, 1974, The Journal of infectious diseases.

Cell-mediated immunity in acute nonlymphocytic leukemia: relationship to host factors, therapy, and prognosis.

P. Wiernik, S. Schimpff, W. Greene, 1974, Blood.

Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.

J. Ruckdeschel, P. Wiernik, S. Schimpff, 1977, Cancer treatment reports.

Handbook of Supportive Care in Cancer

H. Senn, J. Klastersky, S. Schimpff, 1995 .

Ticarcillin in Combination with Cephalothin or Gentamicin as Empiric Antibiotic Therapy in Granulocytopenic Cancer Patients

S. Landesman, H. Standiford, P. Wiernik, 1976, Antimicrobial Agents and Chemotherapy.

Moxalactam and piperacillin: A study of in vitro characteristics and pharmacokinetics in cancer patients

G. Drusano, S. Schimpff, M. Moody, 2005, Infection.

Dilemmas and choices in infection management of the cancer patient.

S. Schimpff, 1989, European journal of cancer & clinical oncology.

Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patients.

J. Bender, P. Wiernik, S. Schimpff, 1979, American journal of hospital pharmacy.

Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later.

P. Wiernik, S. Schimpff, C. Diggs, 1979, The American journal of medicine.

Rectal abscesses in cancer patients.

P. Wiernik, S. Schimpff, J. Block, 1972, Lancet.

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.

H. Standiford, P. Wiernik, S. Schimpff, 1981, The American journal of medicine.

A cooperative investigation of a rational management of granulocytopenic febrile cancer patients

H. Gaya, J. Klastersky, S. Schimpff, 1982 .

Infection in the neutropenic patient: directions for future research

S. Schimpff, 1993, Supportive Care in Cancer.

Double β-lactam regimen compared to an aminoglycoside/β-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients

R. Finley, S. Schimpff, J. Joshi, 1993, Supportive Care in Cancer.

Occasional notes. Please don't eat the salads.

J. Remington, S. Schimpff, 1981, The New England journal of medicine.

Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.

D. Johnson, J. Warren, S. Schimpff, 1983, The Journal of antimicrobial chemotherapy.

PIPERACILLIN AND ALLERGIC RASH

S. Schimpff, J. Howard Scarffe, C. C. Chan, 1985, The Lancet.

Bacterial Infections in Neutropenic Patients

S. Schimpff, C. Jongh, 1983 .

Epithelioid granulomas in Hodgkin disease. A favorable prognostic sign?

M. O’connell, R. Kirschner, P. Wiernik, 1975, JAMA.

The effects of acidemia and hypoxemia on digitalis tolerance

S. Schimpff, 1967 .

Hickman catheters in association with intensive cancer chemotherapy

W. P. Reed, S. Schimpff, J. Wade, 1993, Supportive Care in Cancer.

Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.

R. Finley, J. Aisner, P. Wiernik, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Empiric therapy for the febrile neutropenic patient

S. Schimpff, 1998, Supportive Care in Cancer.

Infectious complications in bone marrow transplantation

J. Klastersky, S. Schimpff, 1993 .

Infection in bone marrow transplantation: a model for examining predisposing factors to infection in cancer patients.

S. Schimpff, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Intravenous sulfamethoxazole-trimethoprim plus ticarcillin as empiric antibiotic therapy for granulocytopenic patient.

S. Schimpff, 1981, Archives of Internal Medicine.

Psychiatric Disorders in Cancer Patients

F. Stiefel, D. Razavi, H. Senn, 1999 .

Well differentiated thyroid carcinoma: epidemiology, etiology and treatment.

S. Schimpff, 1979, The American journal of the medical sciences.

Is Mycobacterium avium paratuberculosis the Trigger in the Crohn’s Disease Spectrum?

R. Redfield, S. Schimpff, P. Saleeb, 2017, Open Forum Infectious Diseases.

Systemic complications of mer immunotherapy of cancer. Pulmonary granulomatosis and rash

P. Wiernik, S. Schimpff, K. Lichtenfeld, 1979, Cancer.

Venous access devices utilized in association with intensive cancer chemotherapy.

W. P. Reed, S. Schimpff, J. Wade, 1989, European Journal of Cancer and Clinical Oncology.

Serum bactericidal test in volunteers — A review

G. Drusano, H. Standiford, S. Schimpff, 1986, European Journal of Clinical Microbiology.

Hypothermia in Hypoglycemia

J. Baxter, P. Felig, S. Schimpff, 1969 .

Role of antimicrobial synergism in infected granulocytopenic patients.

D. Johnson, H. Standiford, S. Schimpff, 1984, European journal of cancer & clinical oncology.

Piperacillin Sodium: Antibacterial Spectrum, Pharmacokinetics, Clinical Efficacy, and Adverse Reactions

R. Finley, S. Schimpff, C. Fortner, 1982, Pharmacotherapy.

Origin of Infection in Acute Nonlymphocytic Leukemia

G. D. Vermeulen, P. Wiernik, S. Schimpff, 2020 .

Evaluation of radiotherapay for localized inflammatory skin and perianal lesions in adult leukemia: A porspectively randomized double blind study.

P. Wiernik, S. Schimpff, R. Slawson, 1977, Cancer treatment reports.

Carcinoma of the Thyroid

S. Schimpff, 1980 .

The Future of Health-Care Delivery: Why It Must Change and How It Will Affect You

S. Schimpff, 2012 .

Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

R. Finley, S. Schimpff, J. Joshi, 1993, Supportive Care in Cancer.

Autopsy findings after prolonged catheterization of the right atrium for chemotherapy in acute leukemia.

W. P. Reed, J. Tenney, S. Schimpff, 1985, Surgery, gynecology & obstetrics.

High‐dose daunorubicin therapy for acute nonlymphocytic leukemia: Correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity

R. Benjamin, N. Bachur, P. Wiernik, 1972, Cancer.

Empiric antibiotic therapy for granulocytopenic patients.

S. Schimpff, 1982, Bulletin of the New York Academy of Medicine.

Pseudomonas aeruginosa Resistant to Carbenicillin and Gentamicin

P. Wiernik, S. Schimpff, V. M. Young, 2020 .

Epithelioid Granulomas Revisited: Long‐Term Follow‐Up in Hodgkin's Disease

S. Schimpff, J. Abrams, Paula Pearl, 1988, American journal of clinical oncology.

Do water pipes prevent transmission of fungi from contaminated marijuana?

S. Schimpff, R. Wharton, N. Schnaper, 1982, The New England journal of medicine.

Axillary lesions in patients with acute leukemia. Evaluation of a preventive program

S. Schimpff, J. Murillo, M. Brouillet, 1979, Cancer.

Hepatitis in patients with acute nonlymphocytic leukemia.

J. Hoofnagle, M. Gaffey, C. Schiffer, 1983, The American journal of medicine.

Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever—Reply

L. Young, R. Feld, D. Armstrong, 1991 .

Role of Vancomycin as a Component of Oral Nonabsorbable Antibiotics for Microbial Suppression in Leukemic Patients

J. Bender, P. Wiernik, S. Schimpff, 1979, Antimicrobial Agents and Chemotherapy.

Evaluation of levamisole as an adjuvant to chemotherapy for treatment of ANLL

C. Schiffer, P. Wiernik, S. Schimpff, 1983, Cancer.

Solving the crisis in primary care

S. Schimpff, 2014 .

Supportive Care In Cancer: A Handbook For Oncologists

H. Senn, J. Klastersky, S. Schimpff, 1999 .

Seventy-five patient-years’ experience with right atrial catheters for chemotherapy

W. P. Reed, P. Wiernik, S. Schimpff, 1983 .

Antibiotic Prophlaxis in Acute Leukemia

P. Wiernik, S. Schimpff, C. Jongh, 1981 .